Literature DB >> 1531224

Effect of Escherichia coli nusG function on lambda N-mediated transcription antitermination.

S L Sullivan1, D F Ward, M E Gottesman.   

Abstract

The Escherichia coli Nus factors act in conjunction with the bacteriophage lambda N protein to suppress transcription termination on the lambda chromosome. NusA binds both N and RNA polymerase and may also interact with other Nus factors. To search for additional components of the N antitermination system, we isolated host revertants that restored N activity in nusA1 mutants. One revertant, nusG4, was mapped to the rif region of the E. coli chromosome and shown to represent a point mutation near the 3' end of the nusG gene. The nusG4 mutation also suppressed nusE71 but not nusASal, nusB5, nusC60 (rpoB60), or nusD026 (rho026). However, nusG+ expressed from a multicopy plasmid suppressed nusD026 and related rho mutants for both lambda and phage T4 growth. These results suggest that NusG may act as a component of the N antitermination complex. In addition, the data imply a role for NusG in Rho-dependent termination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531224      PMCID: PMC206430          DOI: 10.1128/jb.174.4.1339-1344.1992

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  36 in total

1.  Modulation of the two promoters of the galactose operon of Escherichia coli.

Authors:  S Adhya; W Miller
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

Review 2.  Rho-dependent transcription termination.

Authors:  J P Richardson
Journal:  Biochim Biophys Acta       Date:  1990-04-06

3.  An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site.

Authors:  S Barik; B Ghosh; W Whalen; D Lazinski; A Das
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambda.

Authors:  R J Horwitz; J Li; J Greenblatt
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

5.  Construction and characterization of the two hybrid Co1E1 plasmids carrying Escherichia coli tufB gene.

Authors:  A Miyajima; M Shibuya; Y Kaziro
Journal:  FEBS Lett       Date:  1979-06-15       Impact factor: 4.124

Review 6.  Transcription termination and the regulation of gene expression.

Authors:  T Platt
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  Transcriptional mapping of a DNA replication gene cluster in bacteriophage T4. Sites for initiation, termination, and mRNA processing.

Authors:  T Hsu; J D Karam
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

8.  Altered expression of the bacteriophage T4 gene 41 (primase-helicase) in an Escherichia coli rho mutant.

Authors:  D M Hinton
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

9.  Escherichia coli nusB mutations that suppress nusA1 exhibit lambda N specificity.

Authors:  D F Ward; A DeLong; M E Gottesman
Journal:  J Mol Biol       Date:  1983-07-25       Impact factor: 5.469

10.  L factor that is required for beta-galactosidase synthesis is the nusA gene product involved in transcription termination.

Authors:  J Greenblatt; J Li; S Adhya; D I Friedman; L S Baron; B Redfield; H F Kung; H Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  22 in total

1.  Requirement for NusG for transcription antitermination in vivo by the lambda N protein.

Authors:  Ying Zhou; Joshua J Filter; Donald L Court; Max E Gottesman; David I Friedman
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Evidence that the promoter can influence assembly of antitermination complexes at downstream RNA sites.

Authors:  Ying Zhou; Ting Shi; Mark A Mozola; Eric R Olson; Karla Henthorn; Susan Brown; Gary N Gussin; David I Friedman
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

3.  Structural biophysics of the NusB:NusE antitermination complex.

Authors:  Ranabir Das; Sandra Loss; Jess Li; David S Waugh; Sergey Tarasov; Paul T Wingfield; R Andrew Byrd; Amanda S Altieri
Journal:  J Mol Biol       Date:  2007-11-17       Impact factor: 5.469

Review 4.  RNA polymerase elongation factors.

Authors:  Jeffrey W Roberts; Smita Shankar; Joshua J Filter
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

5.  Control of transcription processivity in phage lambda: Nus factors strengthen the termination-resistant state of RNA polymerase induced by N antiterminator.

Authors:  J DeVito; A Das
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  NusG alters rho-dependent termination of transcription in vitro independent of kinetic coupling.

Authors:  K W Nehrke; F Zalatan; T Platt
Journal:  Gene Expr       Date:  1993

7.  Specific binding of Escherichia coli ribosomal protein S1 to boxA transcriptional antiterminator RNA.

Authors:  J Mogridge; J Greenblatt
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

Review 8.  RNA polymerase and the ribosome: the close relationship.

Authors:  Katelyn McGary; Evgeny Nudler
Journal:  Curr Opin Microbiol       Date:  2013-02-22       Impact factor: 7.934

9.  Structural basis for λN-dependent processive transcription antitermination.

Authors:  Nelly Said; Ferdinand Krupp; Ekaterina Anedchenko; Karine F Santos; Olexandr Dybkov; Yong-Heng Huang; Chung-Tien Lee; Bernhard Loll; Elmar Behrmann; Jörg Bürger; Thorsten Mielke; Justus Loerke; Henning Urlaub; Christian M T Spahn; Gert Weber; Markus C Wahl
Journal:  Nat Microbiol       Date:  2017-04-28       Impact factor: 17.745

10.  An α helix to β barrel domain switch transforms the transcription factor RfaH into a translation factor.

Authors:  Björn M Burmann; Stefan H Knauer; Anastasia Sevostyanova; Kristian Schweimer; Rachel A Mooney; Robert Landick; Irina Artsimovitch; Paul Rösch
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.